Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
The stock will change hands under the symbol 'TGIFF'. At the time of writing, shares are up 1.78% at US$0.406.
Proactive takes a look at what's piquing investor interest before the bell in New York
Analysts expect KMG Chemicals Inc to post quarterly earnings at US$0.63 per share on revenue of US$106.60mln
Parsortix harvests circulating tumour cells (CTCs) from blood- a tell-tale early sign of the disease.
Last year, the get-together attracted over 3,200 attendees from 90 countries
The FDA agreed its Investigational New Drug (IND) application for a Phase I trial of drug WP1066
In June this year, the firm announced the purchase of a 91% stake in Alternate Medicine Association (AMA)
Dr Helen Tager-Flusberg has provided the protocol for capturing the primary endpoint of the planned trial for QBM-001.
Analyst Craig Stanley, back from a site visit, repeated a 'buy' on the stock
The Tiple Block acreage is adjacent to Geopark’s prolific Llanos 34 Block
A look at some of the analyst comment on North America listed stocks on Monday
A look at some analyst views from around the City on Friday